Human Health Holdings Limited
HKEX:1419.HK
0.83 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,001.746 | 1,121.793 | 654.712 | 453.737 | 528.585 | 518.02 | 481.147 | 480.258 | 429.538 | 365.246 | 333.933 |
| Cost of Revenue
| 408.51 | 462.108 | 278.023 | 263.898 | 280.345 | 274.446 | 254.987 | 252.21 | 230.293 | 191.527 | 181.74 |
| Gross Profit
| 593.236 | 659.685 | 376.689 | 189.839 | 248.24 | 243.574 | 226.16 | 228.048 | 199.245 | 173.719 | 152.193 |
| Gross Profit Ratio
| 0.592 | 0.588 | 0.575 | 0.418 | 0.47 | 0.47 | 0.47 | 0.475 | 0.464 | 0.476 | 0.456 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 211.184 | 166.703 | 152.372 | 133.092 | 210.725 | 203.696 | 136.511 | 174.035 | 155.879 | 124.938 | 111.035 |
| Selling & Marketing Expenses
| 0.189 | 1.099 | 10.655 | 0 | 0 | 0 | 63.945 | 0 | 0 | 0 | 0 |
| SG&A
| 211.373 | 167.802 | 163.027 | 133.092 | 210.725 | 203.696 | 200.456 | 174.035 | 155.879 | 124.938 | 111.035 |
| Other Expenses
| 1 | 0.517 | -2.078 | -21.097 | 0.071 | 0.388 | 0 | -2.769 | -1.736 | -0.49 | -2.328 |
| Operating Expenses
| 354.614 | 211.688 | 205.23 | 225.815 | 214.792 | 212.155 | 206.5 | 171.266 | 154.143 | 124.448 | 108.707 |
| Operating Income
| 307.073 | 428.809 | 146.064 | -18.586 | 35.903 | 38.267 | 24.092 | 56.878 | 45.181 | 49.361 | 43.633 |
| Operating Income Ratio
| 0.307 | 0.382 | 0.223 | -0.041 | 0.068 | 0.074 | 0.05 | 0.118 | 0.105 | 0.135 | 0.131 |
| Total Other Income Expenses Net
| -68.257 | 16.453 | 22.756 | -20.426 | -1.18 | -6.481 | -3.995 | -16.667 | 0.079 | 0.09 | 0.147 |
| Income Before Tax
| 238.816 | 445.262 | 168.82 | -39.012 | 34.723 | 31.786 | 20.097 | 40.115 | 45.181 | 49.361 | 43.633 |
| Income Before Tax Ratio
| 0.238 | 0.397 | 0.258 | -0.086 | 0.066 | 0.061 | 0.042 | 0.084 | 0.105 | 0.135 | 0.131 |
| Income Tax Expense
| 57.977 | 69.953 | 24.367 | 1.362 | 8.376 | 8.621 | 7.506 | 12.306 | 9.463 | 8.604 | 7.005 |
| Net Income
| 180.839 | 375.309 | 144.453 | -40.374 | 26.624 | 24.111 | 13.469 | 27.809 | 33.727 | 38.748 | 34.093 |
| Net Income Ratio
| 0.181 | 0.335 | 0.221 | -0.089 | 0.05 | 0.047 | 0.028 | 0.058 | 0.079 | 0.106 | 0.102 |
| EPS
| 0.48 | 0.99 | 0.38 | -0.11 | 0.072 | 0.067 | 0.037 | 0.08 | 0.13 | 0.11 | 0.097 |
| EPS Diluted
| 0.48 | 0.99 | 0.38 | -0.11 | 0.072 | 0.067 | 0.037 | 0.08 | 0.13 | 0.11 | 0.097 |
| EBITDA
| 323.459 | 437.634 | 155.849 | -8.087 | 48.086 | 48.565 | 33.38 | 80.019 | 51.906 | 55.207 | 49.641 |
| EBITDA Ratio
| 0.323 | 0.39 | 0.238 | -0.018 | 0.091 | 0.094 | 0.069 | 0.167 | 0.121 | 0.151 | 0.149 |